Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment.

Møller, Christina Tanem; Fosså, Sophie D; Tafjord, Gunnar; Babigumira, Ronnie; Berge, Viktor; Andreassen, Bettina Kulle

Møller, Christina Tanem; Fosså, Sophie D; Tafjord, Gunnar; Babigumira, Ronnie; Berge, Viktor; Andreassen, Bettina Kulle.

Afiliação

Møller CT; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Fosså SD; Faculty of Medicine, University of Oslo, Oslo, Norway.
Tafjord G; Faculty of Medicine, University of Oslo, Oslo, Norway.
Babigumira R; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.
Berge V; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Andreassen BK; Department of Research, Cancer Registry of Norway, Oslo, Norway.

Scand J Urol ; 56(3): 214-220, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35506475

Assuntos

Neoplasias da Bexiga Urinária; Cistectomia; Humanos; Invasividade Neoplásica; Noruega/epidemiologia; Neoplasias da Bexiga Urinária/patologia

Palavras-chave

Muscle-invasive bladder cancer; cystectomy; primary; radiotherapy; secondary; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Scand J Urol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google